Código QR (código de barras bidimensional)

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for etrasimod

ObjectiveTo characterize the post-marketing safety profile of etrasimod using the latest data from the FDA Adverse Event Reporting System (FAERS), and to provide a comparative analysis versus other sphingosine-1-phosphate (S1P) receptor modulators.MethodsAE reports associated with etrasimod were ret...

ver descrição completa

Na minha lista:
Principais autores: Yingxiu Wu, Wei Ke, Huibiao Li
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2025-11-01
coleção:Frontiers in Pharmacology
Assuntos:
etrasimod
FDA adverse event reporting system
disproportionality analyses
pharmacovigilance
adverse event
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fphar.2025.1693090/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados